PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57,670 | -3.0% | 1,418 | +15.5% | 0.01% | -11.1% |
| Q1 2023 | $59,484 | +44.3% | 1,228 | +13.7% | 0.01% | +50.0% |
| Q4 2022 | $41,224 | -23.7% | 1,080 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $54,000 | +25.6% | 1,080 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $43,000 | +7.5% | 1,080 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $40,000 | -7.0% | 1,080 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $43,000 | +7.5% | 1,080 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $40,000 | -13.0% | 1,080 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $46,000 | -9.8% | 1,080 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $51,000 | -10.5% | 1,080 | +16.1% | 0.01% | -11.1% |
| Q4 2020 | $57,000 | +119.2% | 930 | +66.4% | 0.01% | +80.0% |
| Q3 2020 | $26,000 | +100.0% | 559 | +124.5% | 0.01% | +66.7% |
| Q2 2020 | $13,000 | +18.2% | 249 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | – | 249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |